4
Changes in Ownership
Solid Biosciences Inc. Filed Acc 0001193125-25-308103
Chief Technology Officer sold 2,701 shares at $5.11 ($13,802)
- Chief Technology Officer acquired 7,239 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Herzich Paul Chief Technology Officer | 2025-12-02 | Option exercise 10b5-1 | +7,239 | 29,323 | D | ||
| Herzich Paul Chief Technology Officer | 2025-12-03 | Sale 10b5-1 | −2,701 | $5.11 | $13,802 | 26,622 | D |
| Derivatives | |||||||
| Herzich Paul Chief Technology Officer | 2025-12-02 | Option exercise · Restricted Stock Units 10b5-1 | −7,239 | 7,239 | D | ||
| Open-market sales · 2,701 sh · avg $5.11 · $13,802 | |||||||
Loading xslF345X05/ownership.xml…